Generate Investment Management Ltd decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 95.1% in the first quarter, HoldingsChannel.com reports. The fund owned 989 shares of the medical equipment provider’s stock after selling 19,265 shares during the period. Generate Investment Management Ltd’s holdings in Intuitive Surgical were worth $456,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in ISRG. Newbridge Financial Services Group Inc. lifted its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at about $25,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical in the fourth quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. raised its stake in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Down 0.9%
Shares of ISRG opened at $402.95 on Tuesday. The stock has a market cap of $142.71 billion, a P/E ratio of 48.84, a P/E/G ratio of 3.31 and a beta of 1.46. The business’s 50 day moving average price is $437.39 and its 200-day moving average price is $488.76. Intuitive Surgical, Inc. has a 52 week low of $396.68 and a 52 week high of $603.88.
Insider Transactions at Intuitive Surgical
In other news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 7,169 shares of company stock valued at $3,059,135. Insiders own 0.60% of the company’s stock.
Analysts Set New Price Targets
ISRG has been the topic of several research reports. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Leerink Partners lowered their target price on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Robert W. Baird lifted their price target on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Piper Sandler reaffirmed an “overweight” rating and issued a $580.00 price target on shares of Intuitive Surgical in a research note on Tuesday, June 2nd. Finally, Evercore reduced their price target on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $573.42.
Read Our Latest Stock Analysis on ISRG
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
